Presentations: Henry Glick, PhD
2001 | 2002 | 2003 | 2004 |
2005 | 2006 | 2007
2007
How to incorporate economic evaluations into clinical trials: an overview of design and analysis,
Research Priorities in Ambulatory Management of Obstructive Sleep Apnea Workshop, Washington, D.C.,
October 15, 2007.
Designing Economic Evaluations in Randomized Trials, Center for Health Care Research & Policy, MetroHealth
Medical Center, Cleveland, Ohio, January 5, 2007.
Health Care Costs Associated with Elevated Body Mass Index,
Center for Health Care Research & Policy, MetroHealth Medical Center, Cleveland, Ohio, January 5, 2007.
2006
"Standard" Versus "Event-Based" Approaches in Economic Analysis,
Issues Panel 6, Event Based Analysis for Economic Analysis: Sensible Response to Reduce Noise or Dangerous
Violation of the Randomization Principle?, ISPOR 9th Annual European Congress, October 31, 2006. Health Care costs Associated with
Elevated Body Mass Index and the Costs-Effectiveness of Weight Loss, with Adam Gilden Tsai, Nursing 313/513
Obesity and Society, University of Pennsylvania, October 19, 2006. Economic Assessment in Clinical Trials, Invited
Workshop #9, Society for Clinical Trials, May 24, 2006, Orlando, Florida.
Beware of Logs: Issues to Consider When Asking, "To Log of Not to Log?",
Jalpa Doshi, Jieling Chen, and Henry Glick, Contributed Workshop W4, ISPOR, May 22, 2006.
2005
Transferability of the Results From Multinational Trials, Amgen Multinational Studies Advisory Board,
San Francisco, CA, December 16, 2005. Transferability of the Results From
Multinational trials, Astra Zeneca Methods Seminar, December 6, 2005.
Pharmacoeconomics, Wyeth Global Positioning Program, Wharton Executive Education Program, University of
Pennsylvania, November 30, 2005.
Health Care costs Associated with Elevated Body Mass Index and the Costs-Effectiveness of Weight Loss, with
Adam Gilden Tsai, Nursing 313/513 Obesity and Society, University of Pennsylvania, October 19, 2005. The Role of Trial-Based Economic Evaluation in Health Care Decision Making,
iHEA, July 2005.
Issues and pitfalls related to estimating the cost of intervention in applying cost-effectiveness models from
developed countries to developing countries Contributed Session, "Feasibility and pitfalls in applying
cost-effectiveness simulation models of chronic diseases in developed countries to economic evaluation in
developing countries," iHEA, July, 2005.
Analysis of Costs using Patient Level Data from Randomized Designs and
Comparison of Costs and Effects with
Assessment of Stochastic Uncertainty, with Jalpa Doshi, Astra Zeneca Methods Seminar, May 31, 2005. -
Analysis of Costs Using Patient Level Data from Randomized Designs, and
Comparison of Costs and Effects with
Assessment of Stochastic Uncertainty Contributed Workshop W10, ISPOR, May, 2005.
2004
Cost-Effeciveness Analysis: New
Methodologic Approaches, Presentation by Henry Glick at the Center for the Advancement of Research Methods and
Analysis (CARMA), Virginia Commonwealth University, Richmond, Virginia, March 2004. Economic Evaluation in Randomized Trials.
Presentation by Henry Glick at the World Wide Outcomes Research Forum 2004, Pfizer, Inc., New York. ISPOR May, 2004. Issues Panel: Stratified
Cost-Effectiveness Analysis: The Risks and Rewards of Looking at Subgroups. Policy Inference for Cost-Effectiveness
Analysis, Presentation by Henry Glick at Health Economics Research Programme at the University of Oslo - HERO,
December 2004.
2003
2002
2001
- "How to Really Measure Cost-Effectiveness"
32nd Annual Symposium, "Clinical Microbiology Update 2001" Eastern Pennsylvania Branch, American Society
for Microbiology, Adam's Mark Hotel, Philadelphia, PA November 15-16, 2001.
Short Course #3 "Prospective Economic Evaluation
of Clinical Trials: Methods and Analysis" 23rd Annual Meeting of the Society for Medical Decision
Making (SMDM) San Diego, CA, October 21, 2001. Assessing the Generalizability of the Results of
Multinational Trials for Individual Countries Participating in the Trial Henry Glick, University of
Pennsylvania, iHEA 2001. Economic Evaluation in Randomized Trials
Presentation by Henry Glick, University of Pennsylvania, ISTACH 2001. Measuring Treatment Costs in Randomized Trials
Presentation by Daniel Polsky and Henry Glick, University of Pennsylvania, ISTACH 2001. Assessing the Generalizability of Results from
Multinational and Multicenter Clinical Trials Presentation by John Cook1, Joseph Heyes1,
Michael Drummond2, and Henry Glick3 1Merck Research Labs, 2University of York,
3University of Pennsylvania. , ISTACH 2001. Evaluating the Representativeness of the Pooled
Trial-Wide Economic Results of a Multinational Clinical Trial for the Individual Countries that Participated in the
Trial Scientific Paper Presentations,"Building Bridges between Policy, Providers, Patients, and
Industry. Internaional Society of Technology Assessment in Health Care (ISTAHC) Philadelphia, PA, June 4,
2001. "Economic Assessments in Clinical Trials: Design and Analysis," Drug Information Association,
London, England, February 14, 2001. (see DIA Workshop
webpage for complete listing of all presenations for this workshop). Economic Evaluation in Randomized Trials
Pre-Meeting Workshop, "Economic Assessments in Clinical Trials: Design and Analysis," Drug
Information Association, London, England, February 14, 2001. Assessing the Generalizability of the Results of
Multinational Trials for Individual Countries Participating in the Trial Pre-Meeting Workshop,
"Economic Assessments in Clinical Trials: Design and Analysis," Drug Information Association, London, England,
February 14, 2001. Confidence Intervals and Acceptability in Cost
Effectiveness Analysis "Economic Assessments in Clinical Trials: Design and Analysis," Drug Information
Association, London, England February 16, 2001.
Top ^
|
